Sonoma Pharmaceuticals, Inc. Warrant 2016-21.01.20 on Sonoma Pharmaceuticals
(NASDAQ : SNOAW)

( )
SNOAW PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-2.27%166.220.4%$376.39m
AMRNAmarin Corporation Plc Sponsored ADR
-4.82%14.802.0%$117.16m
JAZZJazz Pharmaceuticals Plc
-0.17%138.252.2%$110.84m
PRGOPerrigo Co. Plc
-1.83%55.356.8%$66.11m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-5.32%112.816.3%$52.73m
MNKMallinckrodt Plc
0.76%18.6721.1%$52.38m
ICLRICON Plc
0.41%130.444.1%$44.93m
UTHRUnited Therapeutics Corporation
-0.46%106.1014.4%$38.70m
ICPTIntercept Pharmaceuticals, Inc.
1.45%106.7418.6%$37.74m
SAGESAGE Therapeutics, Inc.
-2.74%98.559.6%$36.74m
HZNPHorizon Pharma plc
-1.20%19.767.4%$34.83m
CTLTCatalent Inc
-2.95%33.232.4%$31.43m
ENDPEndo International Plc
-2.65%9.198.9%$30.16m
ZGNXZogenix, Inc.
-5.25%37.729.9%$25.34m
MDCOMedicines Company
3.83%18.6921.8%$24.70m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.